Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2019

Proffered paper session - Breast cancer

Subgroup analysis of IMpassion130: Atezolizumab + nab-paclitaxel (nab-P) in patients (pts) with advanced triple-negative breast cancer (TNBC) in Asian countries

Date

23 Nov 2019

Session

Proffered paper session - Breast cancer

Topics

Tumour Site

Breast Cancer

Presenters

Hiroji Iwata

Citation

Annals of Oncology (2019) 30 (suppl_9): ix13-ix19. 10.1093/annonc/mdz418

Authors

H. Iwata1, S. Im2, J. Sohn3, K.H. Jung4, Y. Im5, K.S. Lee6, K. Inoue7, K. Tamura8, A. Wong9, L.A. Emens10, C.H. Barrios11, S. Adams12, A. Schneeweiss13, V. Diéras14, E.P. Winer15, S.Y. Chui16, V. Henschel17, H.S. Rugo18, S. Loi19, P. Schmid20

Author affiliations

  • 1 Breast Oncology Dept., Aichi Cancer Center, 464-8681 - Nagoya/JP
  • 2 Department Of Internal Medicine, Seoul National University Hospital, Seoul/KR
  • 3 Division Of Medical Oncology, Yonsei Cancer Center, Yonsei University Health System, Seodaemun‐gu/KR
  • 4 Department Of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul/KR
  • 5 Division Of Hematology/medical Oncology, Department Of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul/KR
  • 6 Center For Breast Cancer, Research Institute and Hospital, National Cancer Center, 138-931 - Goyang/KP
  • 7 Division Of Breast Oncology, Saitama Cancer Center, Saitama/JP
  • 8 Breast And Medical Oncology, National Cancer Center Hospital (NCCH), Tokyo/JP
  • 9 Department Of Haematology-oncology, National University Cancer Institute, Singapore/SG
  • 10 Upmc Hillman Cancer Center, Magee Women’s Hospital, 15232 - Pittsburgh/US
  • 11 Centro De Pesquina Clínica, HSL, PUCRS, 90619-900 - Porto Alegre/BR
  • 12 Langone Medical Center, New York University, New York/US
  • 13 University Hospital Heidelberg, National Center for Tumor Diseases, 69115 - Heidelberg/DE
  • 14 Department Of Medical Oncology, Centre Eugene Marquis, Rennes/FR
  • 15 Medical Oncology, Dana-Farber Cancer Institute, 2115 - Boston/US
  • 16 Product Development Oncology, Genentech, Inc., South San Francisco/US
  • 17 Bio-statistics, F. Hoffmann-La Roche, Basel/CH
  • 18 Department Of Medicine, University of California San Francisco, 94115 - San Francisco/US
  • 19 Translational Breast Cancer Genomics Lab, Division Of Research, Peter MacCallum Cancer Center, 3002 - Melbourne/AU
  • 20 Queen Mary University Of London, Barts Cancer Institute, EC1M 6BQ - London/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.